Patents by Inventor Lance Hammerland

Lance Hammerland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anthelmintic combinations and methods of use thereof
    Patent number: 10993988
    Abstract: The present invention relates to a veterinary composition comprising an effective amount of at least one cyclic depsipeptide and at least one macrocyclic lactone; and a pharmaceutically acceptable carrier, for the treatment or prophylaxis of parasitic infection in a mammal wherein the parasite shows resistance to treatment or prophylaxis with the macrocyclic lactone alone.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: May 4, 2021
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Brenda Bondesen, Lance Hammerland
  • Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays
    Patent number: 10345292
    Abstract: The following discloses mammalian cells lines that stably express functional nematode acetylcholine receptor subunits. The resulting expression of functional ion channels has been made possible by the stable co-expression of the chaperone protein, RIC3. These cell lines are extremely useful for the high throughput screening (HTS) of compounds, to identify new candidate parasiticidal, including nematocidal, active ingredients.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: July 9, 2019
    Assignees: BOEHRINGER INGELHEIM ANIMAL HEALTH INC., SANOFI
    Inventors: Lance Hammerland, Brenda Bondesen, Jean-Marie Chambard, Thierry Vermat, Werner Dittrich, Michel Partiseti, Qing Zhou-Liu, Cathy Cojean, Rachid Boukaiba, Eric Tagat
  • Mammalian Cell Lines Expressing Functional Nematode Acetylcholine Receptors and Use thereof for High-Throughput Screening Assays
    Publication number: 20170067873
    Abstract: The following discloses mammalian cells lines that stably express functional nematode acetylcholine receptor subunits. The resulting expression of functional ion channels has been made possible by the stable co-expression of the chaperone protein, RIC3. These cell lines are extremely useful for the high throughput screening (HTS) of compounds, to identify new candidate parasiticidal, including nematocidal, active ingredients.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 9, 2017
    Applicants: MERIAL, INC., SANOFI
    Inventors: Lance Hammerland, Brenda Bondesen, Jean-Marie Chambard, Thierry Vermat, Werner Dittrich, Michel Partiseti, Qing Zhou-Liu, Cathy Cojean, Rachid Boukaiba, Eric Tagat
  • ANTHELMINTIC COMBINATIONS AND METHODS OF USE THEREOF
    Publication number: 20170020955
    Abstract: The present invention relates to a veterinary composition comprising an effective amount of at least one cyclic depsipeptide and at least one macrocyclic lactone; and a pharmaceutically acceptable carrier, for the treatment or prophylaxis of parasitic infection in a mammal wherein the parasite shows resistance to treatment or prophylaxis with the macrocyclic lactone alone.
    Type: Application
    Filed: April 1, 2016
    Publication date: January 26, 2017
    Applicant: MERIAL, INC.
    Inventors: Brenda Bondesen, Lance Hammerland